Paediatric and Adolescent Treatment

 

On Thursday August 9, 2018, Dr. Lynne Mofenson presented selected abstracts on PMTCT, children and adolescents presented at the 10th International Workshop…

WHO Policy Brief: 2018 optimal formulary and limited-use list for paediatric ARVs

The WHO 2018 guideline update promotes the use of optimal treatment regimens in all populations. Though new, more effective and better tolerated options with a higher…

CSWG Policy Brief: Providing peer support for adolescents and young people living with HIV

WHO recommends peer support, including peer counseling, for adolescents and young people living with HIV age 10-24 years (AYPLHIV). Peer support enables providers,…

CSWG Policy Brief: Preventing and treating tuberculosis among children living with HIV

Tuberculosis (TB) is a major contributor to morbidity and mortality in children living with HIV (CLHIV), particularly in TB endemic settings. TB in CLHIV is a

CSWG Brief: Scaling up optimal antiretroviral treatment for children: A long overdue intervention

To achieve an AIDS-free generation, optimal treatment options for all infants and young children living with HIV must be available, tolerable and most importantly,…

CSWG Policy Brief: Meaningful engagement of adolescents and young people in national and local HIV programming

Adolescents and young people (AYP) (10-24 years) are being left behind in the HIV response, with high levels of new infections, and lower levels of diagnosis and…

CSWG Policy Brief: Family-based index case testing to identify children with HIV

Paediatric HIV treatment coverage is stagnating. The most recent estimates suggest that only 46% of children living with HIV are on treatment, well below the AIDS…

Child Survival Working Group - Policy Briefs

Urgent and ambitious 2020 global targets are on the horizon, yet there has been insufficient progress in paediatric and adolescent HIV to date. Scaling up HIV…

,

Learn more in the Foreword and download the briefs…

CSWG Policy Brief: Sensitizing health workers to providing responsive care for adolescents and young people living with HIV

The 95-95-95 targets will only be achieved with zero discrimination, including within healthcare settings. Health worker attitudes, including those of professional…

CSWG Policy Brief: Engaging community and faith-based organizations to deliver PMTCT and pediatric HIV services

To reach global pediatric HIV targets, efforts must extend beyond clinic doors. Community-based organisations (CBOs), faith-based organisations (FBOs) and places of…

CSWG Policy Brief: Point-of-care testing as a solution for timely early infant diagnosis

Despite remarkable progress in prevention of mother-to-child transmission of HIV (PMTCT), 160,000 children were newly infected with HIV in 2016. Less than half of HIV…

CSWG Policy Brief: Providing differentiated service delivery to children and adolescents

Children and adolescents living with HIV (CALHIV) have a lifetime of antiretroviral therapy (ART) ahead of them. An estimated 95% of HIV service delivery is currently…